drugset / Trial / NCT02626338
Pilot Study of Crenolanib Combined With Standard Salvage Chemotherapy in Subjects With R/R AML
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The proposed study is designed to combine crenolanib with standard salvage chemotherapy to treat patients with R/R AML irrespective the FLT3 status.
Timeline
- Start
- 2016-02
- Primary completion
- 2018-02
- Completion
- 2018-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Crenolanib | Small molecule | — | — |
| Background | Cytarabine | Small molecule | — | — |
| Background | Etoposide | Small molecule | — | — |
| Background | Fludarabine | Small molecule | — | — |
| Background | G-CSF | Unknown | — | — |
| Background | Idarubicin | Small molecule | — | — |
| Background | Mitoxantrone | Small molecule | — | — |